MedArrive; Alma; Abridge; Gilboa Therapeutics; Wheel; OneOncology; Capital Rx; Turquoise Health; Anna Kim/Insider
The year 2022 was a reckoning for healthcare startups.
After years of record funding, a market downturn in 2022 sent buzzy companies back down to Earth.
We asked the investors to name companies from their firms' portfolios, as well as ones they haven't invested in. We noted when investors have stakes in the companies they nominated.
Some investors picked companies on the brink of